
Please try another search
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Name | Age | Since | Title |
---|---|---|---|
Patrick D. Walsh | 63 | 2018 | Independent Chairman |
Thomas J. Haughey | 60 | 2018 | Independent Director |
Antonio R. Pera | 67 | 2020 | Independent Director |
Matthew J. Leonard | 57 | 2023 | Independent Director |
Muthusamy Shanmugam | 56 | 2021 | Head of R&D, COO of New Jersey Operations & Director |
Jeanne A. Thoma | 66 | 2020 | Independent Director |
Renee P. Tannenbaum | 73 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review